NCT06828952

Brief Summary

From this study, it can be concluded that patients who meet the following criteria are more likely to fail expectant management and thus should not be considered for the NOM of uncomplicated acute appendicitis. These include the duration of symptoms before presenting to a surgical emergency , the presence of fever within 24 hours of presenting to a surgical emergency, TLC cells/dL, CRP mg/L, appendix diameter mm, modified Alvarado score , and adult appendicitis score .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 17, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

June 22, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2025

Completed
Last Updated

February 17, 2025

Status Verified

December 1, 2024

Enrollment Period

5 months

First QC Date

December 4, 2024

Last Update Submit

February 13, 2025

Conditions

Keywords

Appendicitis

Outcome Measures

Primary Outcomes (1)

  • Risk factors of failure of conservative treatment in acute non complicated appendicitis

    modified Alvarado score and adult appendicitis score

    One year

Study Arms (1)

(1) Male or female patients é diagnosis of acute appendicitis.

Patients who presented with complaints of right lower quadrant pain with symptoms and signs strongly suggestive of uncomplicated acute appendicitis that was confirmed on ultrasonography, were included. The modified Alvarado score and adult appendicitis score were calculated.

Drug: ceftriaxoneDrug: ceftriaxone 1 gm/12 hourly and IV metronidazole 500 mg/8 hourly

Interventions

ceftriaxone 1 gm/12 hourly and IV metronidazole 500 mg/8 hourly

(1) Male or female patients é diagnosis of acute appendicitis.

Conservative management

(1) Male or female patients é diagnosis of acute appendicitis.

Eligibility Criteria

Age16 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Male or female patients é diagnosis of acute appendicitis Patients with ages: from 16 to 60 years old

You may qualify if:

  • Male or female patients é diagnosis of acute appendicitis .
  • Patients with ages: from 16 to 60 years old.

You may not qualify if:

  • complicated AA (appendicolith, perforation, peri appendicular abscess or suspicion of a tumor).
  • inflammatory bowel disease.
  • inability to co-operate and give informed consent.
  • diffuse peritonitis.
  • antibiotic documented allergy \& allergy to contrast media .
  • Patients with serious comorbid conditions DM \& renal insufficiency, serum creatinine \> 150 μmol/l .
  • Pregnant \& lactating patient.
  • Patients with bleeding diathesis and those on anticoagulants.
  • Patients with advanced malignancies \& patient on immunosuppressive drugs .
  • Patients with previous appendectomy.
  • Extreme of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, 71515, Egypt

Location

Related Publications (5)

  • Shindoh J, Niwa H, Kawai K, Ohata K, Ishihara Y, Takabayashi N, Kobayashi R, Hiramatsu T. Predictive factors for negative outcomes in initial non-operative management of suspected appendicitis. J Gastrointest Surg. 2010 Feb;14(2):309-14. doi: 10.1007/s11605-009-1094-1.

    PMID: 19936849BACKGROUND
  • Hansson J, Khorram-Manesh A, Alwindawe A, Lundholm K. A model to select patients who may benefit from antibiotic therapy as the first line treatment of acute appendicitis at high probability. J Gastrointest Surg. 2014 May;18(5):961-7. doi: 10.1007/s11605-013-2413-0. Epub 2013 Nov 22.

    PMID: 24263678BACKGROUND
  • Walker C, Moosavi A, Young K, Fluck M, Torres D, Widom K, Wild J. Factors Associated with Failure of Nonoperative Management for Complicated Appendicitis. Am Surg. 2019 Aug 1;85(8):865-870.

    PMID: 31560305BACKGROUND
  • Loftus TJ, Brakenridge SC, Croft CA, Stephen Smith R, Efron PA, Moore FA, Mohr AM, Jordan JR. Successful nonoperative management of uncomplicated appendicitis: predictors and outcomes. J Surg Res. 2018 Feb;222:212-218.e2. doi: 10.1016/j.jss.2017.10.006. Epub 2017 Nov 13.

    PMID: 29146455BACKGROUND
  • Cervellin G, Mora R, Ticinesi A, Meschi T, Comelli I, Catena F, Lippi G. Epidemiology and outcomes of acute abdominal pain in a large urban Emergency Department: retrospective analysis of 5,340 cases. Ann Transl Med. 2016 Oct;4(19):362. doi: 10.21037/atm.2016.09.10.

    PMID: 27826565BACKGROUND

Related Links

MeSH Terms

Conditions

Appendicitis

Interventions

CeftriaxoneMetronidazole

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsGastroenteritisGastrointestinal DiseasesDigestive System DiseasesCecal DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

CefotaximeCephacetrileCephalosporinsbeta-LactamsLactamsAmidesOrganic ChemicalsThiazinesSulfur CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsNitroimidazolesNitro CompoundsImidazolesAzolesHeterocyclic Compounds, 1-Ring

Central Study Contacts

Ahmed Mohammed Hussein Sayed Ahmed Razeen, MBBCh

CONTACT

Mohamed Taher Gamal Amin Taher, MBBCh &MD &PHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 4, 2024

First Posted

February 17, 2025

Study Start

June 22, 2025

Primary Completion

December 1, 2025

Study Completion

December 2, 2025

Last Updated

February 17, 2025

Record last verified: 2024-12

Locations